{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:12:39Z","timestamp":1792177959012,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T00:00:00Z","timestamp":1302220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genet Vaccines Ther"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The envelope glycoprotein of lymphocytic choriomeningitis virus (LCMV) can efficiently pseudotype lentiviral vectors. Some strains of LCMV exploit high affinity interactions with \u03b1-dystroglycan (\u03b1-DG) to bind to cell surfaces and subsequently fuse in low pH endosomes. LCMV strains with low \u03b1-DG affinity utilize an unknown receptor and display unique tissue tropisms. We pseudotyped non-primate feline immunodeficiency virus (FIV) vectors using LCMV derived glycoproteins with high or low affinity to \u03b1-DG and evaluated their properties <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We pseudotyped FIV with the LCMV WE54 strain envelope glycoprotein and also engineered a point mutation in the WE54 envelope glycoprotein (L260F) to diminish \u03b1-DG affinity and direct binding to alternate receptors. We hypothesized that this change would alter <jats:italic>in vivo<\/jats:italic> tissue tropism and enhance gene transfer to neonatal animals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In mice, hepatic \u03b1- and \u03b2-DG expression was greatest at the late gestational and neonatal time points. When displayed on the surface of the FIV lentivirus the WE54 L260F mutant glycoprotein bound weakly to immobilized \u03b1-DG. Additionally, LCMV WE54 pseudotyped FIV vector transduction was neutralized by pre-incubation with soluble \u03b1-DG, while the mutant glycoprotein pseudotyped vector was not. <jats:italic>In vivo<\/jats:italic> gene transfer in adult mice with either envelope yielded low transduction efficiencies in hepatocytes following intravenous delivery. In marked contrast, neonatal gene transfer with the LCMV envelopes, and notably with the FIV-L260F vector, conferred abundant liver and lower level cardiomyocyte transduction as detected by luciferase assays, bioluminescent imaging, and \u03b2-galactosidase staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These results suggest that a developmentally regulated receptor for LCMV is expressed abundantly in neonatal mice. LCMV pseudotyped vectors may have applications for neonatal gene transfer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Abbreviations<\/jats:title>\n            <jats:p>Armstrong 53b (Arm53b); baculovirus <jats:italic>Autographa californica<\/jats:italic> GP64 (GP64); charge-coupled device (CCD); dystroglycan (DG); feline immunodeficiency virus (FIV); glycoprotein precursor (GP-C); firefly luciferase (Luc); lymphocytic choriomeningitis virus (LCMV); nuclear targeted \u03b2-galactosidase (ntLacZ); optical density (OD); PBS\/0.1% (w\/v) Tween-20 (PBST); relative light units (RLU); Rous sarcoma virus (RSV); transducing units per milliliter (TU\/ml); vesicular stomatitis virus (VSV-G); wheat germ agglutinin (WGA); 50% reduction in binding (C<jats:sub>50<\/jats:sub>).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-0556-9-8","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T21:28:46Z","timestamp":1302298126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Altering \u03b1-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism"],"prefix":"10.1186","volume":"9","author":[{"given":"Douglas E","family":"Dylla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Paul B","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,8]]},"reference":[{"key":"89_CR1","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/JVI.76.3.1488-1495.2002","volume":"76","author":"WR Beyer","year":"2002","unstructured":"Beyer WR, Westphal M, Ostertag W, von Laer D: Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol. 2002, 76: 1488-1495.","journal-title":"J Virol"},{"key":"89_CR2","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1128\/JVI.73.7.6114-6116.1999","volume":"73","author":"H Miletic","year":"1999","unstructured":"Miletic H, Bruns M, Tsiakas K, Vogt B, Rezai R, Baum C, Kuhlke K, Cosset FL, Ostertag W, Lother H, von Laer D: Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol. 1999, 73: 6114-6116.","journal-title":"J Virol"},{"key":"89_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virol.2006.05.018","volume":"353","author":"T Reignier","year":"2006","unstructured":"Reignier T, Oldenburg J, Noble B, Lamb E, Romanowski V, Buchmeier MJ, Cannon PM: Receptor use by pathogenic arenaviruses. Virology. 2006, 353: 111-120.","journal-title":"Virology"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1128\/jvi.66.12.7270-7281.1992","volume":"66","author":"P Borrow","year":"1992","unstructured":"Borrow P, Oldstone MB: Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J Virol. 1992, 66: 7270-7281.","journal-title":"J Virol"},{"key":"89_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0042-6822(86)90020-6","volume":"153","author":"BS Parekh","year":"1986","unstructured":"Parekh BS, Buchmeier MJ: Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology. 1986, 153: 168-178.","journal-title":"Virology"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","volume":"282","author":"W Cao","year":"1998","unstructured":"Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB: Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 1998, 282: 2079-2081.","journal-title":"Science"},{"key":"89_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/002215549804600404","volume":"46","author":"M Durbeej","year":"1998","unstructured":"Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P: Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem. 1998, 46: 449-457.","journal-title":"J Histochem Cytochem"},{"key":"89_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1083\/jcb.130.1.79","volume":"130","author":"M Durbeej","year":"1995","unstructured":"Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P: Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol. 1995, 130: 79-91.","journal-title":"J Cell Biol"},{"key":"89_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1432-0436.2001.690206.x","volume":"69","author":"M Durbeej","year":"2001","unstructured":"Durbeej M, Talts JF, Henry MD, Yurchenco PD, Campbell KP, Ekblom P: Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation. 2001, 69: 121-134.","journal-title":"Differentiation"},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"26609","DOI":"10.1074\/jbc.274.37.26609","volume":"274","author":"M Durbeej","year":"1999","unstructured":"Durbeej M, Campbell KP: Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem. 1999, 274: 26609-26616.","journal-title":"J Biol Chem"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1128\/JVI.75.1.448-457.2001","volume":"75","author":"SC Smelt","year":"2001","unstructured":"Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H, Campbell KP, Oldstone MB: Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J Virol. 2001, 75: 448-457.","journal-title":"J Virol"},{"key":"89_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.virol.2004.05.009","volume":"325","author":"S Kunz","year":"2004","unstructured":"Kunz S, Sevilla N, Rojek JM, Oldstone MB: Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology. 2004, 325: 432-445.","journal-title":"Virology"},{"key":"89_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.virol.2009.02.042","volume":"387","author":"S Kunz","year":"2009","unstructured":"Kunz S: Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. Virology. 2009, 387: 245-249.","journal-title":"Virology"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0042-6822(88)90566-1","volume":"164","author":"M Salvato","year":"1988","unstructured":"Salvato M, Shimomaye E, Southern P, Oldstone MB: Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology. 1988, 164: 517-522.","journal-title":"Virology"},{"key":"89_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.200104103","volume":"155","author":"S Kunz","year":"2001","unstructured":"Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB: Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol. 2001, 155: 301-310.","journal-title":"J Cell Biol"},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/JVI.76.10.5140-5146.2002","volume":"76","author":"CF Spiropoulou","year":"2002","unstructured":"Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB: New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol. 2002, 76: 5140-5146.","journal-title":"J Virol"},{"key":"89_CR17","doi-asserted-by":"publisher","first-page":"14297","DOI":"10.1128\/JVI.79.22.14297-14308.2005","volume":"79","author":"M Imperiali","year":"2005","unstructured":"Imperiali M, Thoma C, Pavoni E, Brancaccio A, Callewaert N, Oxenius A: O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. J Virol. 2005, 79: 14297-14308.","journal-title":"J Virol"},{"key":"89_CR18","doi-asserted-by":"publisher","first-page":"14282","DOI":"10.1128\/JVI.79.22.14282-14296.2005","volume":"79","author":"S Kunz","year":"2005","unstructured":"Kunz S, Rojek JM, Kanagawa M, Spiropoulou CF, Barresi R, Campbell KP, Oldstone MB: Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol. 2005, 79: 14282-14296.","journal-title":"J Virol"},{"key":"89_CR19","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","volume":"79","author":"S Kunz","year":"2005","unstructured":"Kunz S, Rojek JM, Perez M, Spiropoulou CF, Oldstone MB: Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan. J Virol. 2005, 79: 5979-5987.","journal-title":"J Virol"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature00837","volume":"418","author":"DE Michele","year":"2002","unstructured":"Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, et al: Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 2002, 418: 417-422.","journal-title":"Nature"},{"key":"89_CR21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/JVI.75.2.1061-1064.2001","volume":"75","author":"WR Beyer","year":"2001","unstructured":"Beyer WR, Miletic H, Ostertag W, von Laer D: Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol. 2001, 75: 1061-1064.","journal-title":"J Virol"},{"key":"89_CR22","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/JVI.73.6.4991-5000.1999","volume":"73","author":"JC Johnston","year":"1999","unstructured":"Johnston JC, Gasmi M, Lim LE, Elder JH, Yee JK, Jolly DJ, Campbell KP, Davidson BL, Sauter SL: Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol. 1999, 73: 4991-5000.","journal-title":"J Virol"},{"key":"89_CR23","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1172\/JCI8390","volume":"104","author":"G Wang","year":"1999","unstructured":"Wang G, Slepushkin V, Zabner J, Keshavjee S, Johnston JC, Sauter SL, Jolly DJ, Dubensky TW, Davidson BL, McCray PB: Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest. 1999, 104: R55-62.","journal-title":"J Clin Invest"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"12818","DOI":"10.1128\/JVI.79.20.12818-12827.2005","volume":"79","author":"PL Sinn","year":"2005","unstructured":"Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray PB: Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol. 2005, 79: 12818-12827.","journal-title":"J Virol"},{"key":"89_CR25","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1128\/JVI.00958-06","volume":"80","author":"SQ Harper","year":"2006","unstructured":"Harper SQ, Staber PD, Beck CR, Fineberg SK, Stein C, Ochoa D, Davidson BL: Optimization of feline immunodeficiency virus vectors for RNA interference. J Virol. 2006, 80: 9371-9380.","journal-title":"J Virol"},{"key":"89_CR26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1089\/hum.2006.127","volume":"18","author":"PL Sinn","year":"2007","unstructured":"Sinn PL, Goreham-Voss JD, Arias AC, Hickey MA, Maury W, Chikkanna-Gowda CP, McCray PB: Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector. Hum Gene Ther. 2007, 18: 1244-1252.","journal-title":"Hum Gene Ther"},{"key":"89_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1994.1001","volume":"198","author":"P Borrow","year":"1994","unstructured":"Borrow P, Oldstone MB: Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology. 1994, 198: 1-9.","journal-title":"Virology"},{"key":"89_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1006\/viro.1994.1057","volume":"198","author":"C Di Simone","year":"1994","unstructured":"Di Simone C, Zandonatti MA, Buchmeier MJ: Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology. 1994, 198: 455-465.","journal-title":"Virology"},{"key":"89_CR29","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1016\/S0021-9258(18)31565-5","volume":"266","author":"JM Ervasti","year":"1991","unstructured":"Ervasti JM, Kahl SD, Campbell KP: Purification of dystrophin from skeletal muscle. J Biol Chem. 1991, 266: 9161-9165.","journal-title":"J Biol Chem"},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0042-6822(81)90137-9","volume":"113","author":"MJ Buchmeier","year":"1981","unstructured":"Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB: Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology. 1981, 113: 73-85.","journal-title":"Virology"},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1128\/JVI.76.18.9378-9388.2002","volume":"76","author":"Y Kang","year":"2002","unstructured":"Kang Y, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD, Ratliff KL, Shen H, Barker CK, Martins I, et al: In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol. 2002, 76: 9378-9388.","journal-title":"J Virol"},{"key":"89_CR32","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"HP Jia","year":"2005","unstructured":"Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB: ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005, 79: 14614-14621.","journal-title":"J Virol"},{"key":"89_CR33","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1128\/JVI.77.10.5902-5910.2003","volume":"77","author":"PL Sinn","year":"2003","unstructured":"Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB: Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol. 2003, 77: 5902-5910.","journal-title":"J Virol"},{"issue":"Pt 4","key":"89_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1099\/0022-1317-71-4-767","volume":"71","author":"MO McClure","year":"1990","unstructured":"McClure MO, Sommerfelt MA, Marsh M, Weiss RA: The pH independence of mammalian retrovirus infection. J Gen Virol. 1990, 71 (Pt 4): 767-773.","journal-title":"J Gen Virol"},{"key":"89_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.virol.2004.01.006","volume":"321","author":"H Garg","year":"2004","unstructured":"Garg H, Fuller FJ, Tompkins WA: Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion. Virology. 2004, 321: 274-286.","journal-title":"Virology"},{"key":"89_CR36","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1099\/vir.0.2008\/004721-0","volume":"89","author":"M Imperiali","year":"2008","unstructured":"Imperiali M, Sporri R, Hewitt J, Oxenius A: Post-translational modification of {alpha}-dystroglycan is not critical for lymphocytic choriomeningitis virus receptor function in vivo. J Gen Virol. 2008, 89: 2713-2722.","journal-title":"J Gen Virol"},{"key":"89_CR37","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1073\/pnas.2634931100","volume":"100","author":"P Zhu","year":"2003","unstructured":"Zhu P, Chertova E, Bess J, Lifson JD, Arthur LO, Liu J, Taylor KA, Roux KH: Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc Natl Acad Sci USA. 2003, 100: 15812-15817.","journal-title":"Proc Natl Acad Sci USA"},{"key":"89_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymthe.2004.11.008","volume":"11","author":"CS Stein","year":"2005","unstructured":"Stein CS, Martins I, Davidson BL: The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain. Mol Ther. 2005, 11: 382-389.","journal-title":"Mol Ther"},{"key":"89_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ana.21193","volume":"62","author":"DJ Bonthius","year":"2007","unstructured":"Bonthius DJ, Nichols B, Harb H, Mahoney J, Karacay B: Lymphocytic choriomeningitis virus infection of the developing brain: critical role of host age. Ann Neurol. 2007, 62: 356-374.","journal-title":"Ann Neurol"},{"key":"89_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/71673","volume":"24","author":"F Park","year":"2000","unstructured":"Park F, Ohashi K, Chiu W, Naldini L, Kay MA: Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet. 2000, 24: 49-52.","journal-title":"Nat Genet"},{"key":"89_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1525-0016(03)00169-2","volume":"8","author":"F Park","year":"2003","unstructured":"Park F, Ohashi K, Kay MA: The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther. 2003, 8: 314-323.","journal-title":"Mol Ther"},{"key":"89_CR42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.1840360629","volume":"36","author":"H Enomoto","year":"2002","unstructured":"Enomoto H, Yoshida K, Kishima Y, Kinoshita T, Yamamoto M, Everett AD, Miyajima A, Nakamura H: Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology. 2002, 36: 1519-1527.","journal-title":"Hepatology"},{"key":"89_CR43","first-page":"865","volume":"34","author":"S Sell","year":"1974","unstructured":"Sell S, Nichols M, Becker FF, Leffert HL: Hepatocyte proliferation and alpha 1-fetoprotein in pregnant, neonatal, and partially hepatectomized rats. Cancer Res. 1974, 34: 865-871.","journal-title":"Cancer Res"},{"key":"89_CR44","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1073\/pnas.192353499","volume":"99","author":"KP Ponder","year":"2002","unstructured":"Ponder KP, Melniczek JR, Xu L, Weil MA, O'Malley TM, O'Donnell PA, Knox VW, Aguirre GD, Mazrier H, Ellinwood NM, et al: Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci USA. 2002, 99: 13102-13107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"89_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymthe.2006.03.015","volume":"14","author":"KP Ponder","year":"2006","unstructured":"Ponder KP, Wang B, Wang P, Ma X, Herati R, Wang B, Cullen K, O'Donnell P, Ellinwood NM, Traas A, et al: Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig. Mol Ther. 2006, 14: 5-13.","journal-title":"Mol Ther"},{"key":"89_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.gt.3302473","volume":"12","author":"B Salani","year":"2005","unstructured":"Salani B, Damonte P, Zingone A, Barbieri O, Chou JY, D'Costa J, Arya SK, Eva A, Varesio L: Newborn liver gene transfer by an HIV-2-based lentiviral vector. Gene Ther. 2005, 12: 803-814.","journal-title":"Gene Ther"},{"key":"89_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1006\/mthe.2002.0527","volume":"5","author":"L Xu","year":"2002","unstructured":"Xu L, Haskins ME, Melniczek JR, Gao C, Weil MA, O'Malley TM, O'Donnell PA, Mazrier H, Ellinwood NM, Zweigle J, et al: Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs. Mol Ther. 2002, 5: 141-153.","journal-title":"Mol Ther"},{"key":"89_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/mthe.2002.0681","volume":"6","author":"TC MacKenzie","year":"2002","unstructured":"MacKenzie TC, Kobinger GP, Kootstra NA, Radu A, Sena-Esteves M, Bouchard S, Wilson JM, Verma IM, Flake AW: Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther. 2002, 6: 349-358.","journal-title":"Mol Ther"},{"key":"89_CR49","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/mt.2010.119","volume":"8","author":"A Grinshpun","year":"2010","unstructured":"Grinshpun A, Condiotti R, S NW, Peer M, Zeig E, Peretz S, Simerzin A, Chou J, Pann CJ, Giladi H, Galun E: Neonatal Gene Therapy of Glycogen Storage Disease Type Ia Using a Feline Immunodeficiency Virus-based Vector. Mol Ther. 2010, 8: 1592-1598.","journal-title":"Mol Ther"},{"key":"89_CR50","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1089\/hum.2010.008","volume":"21","author":"N Carrillo-Carrasco","year":"2010","unstructured":"Carrillo-Carrasco N, Chandler RJ, Chandrasekaran S, Venditti CP: Liver-Directed Recombinant Adeno-Associated Viral Gene Delivery Rescues a Lethal Mouse Model of Methylmalonic Acidemia and Provides Long-Term Phenotypic Correction. Hum Gene Ther. 2010, 21: 1147-1154.","journal-title":"Hum Gene Ther"},{"key":"89_CR51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/gt.2009.160","volume":"17","author":"SO Kyosen","year":"2010","unstructured":"Kyosen SO, Iizuka S, Kobayashi H, Kimura T, Fukuda T, Shen J, Shimada Y, Ida H, Eto Y, Ohashi T: Neonatal gene transfer using lentiviral vector for murine Pompe disease: long-term expression and glycogen reduction. Gene Ther. 2010, 17: 521-530.","journal-title":"Gene Ther"},{"key":"89_CR52","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1126\/science.271.5256.1723","volume":"271","author":"JP Ridge","year":"1996","unstructured":"Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 1996, 271: 1723-1726.","journal-title":"Science"},{"key":"89_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.thromres.2006.09.010","volume":"120","author":"L Xu","year":"2007","unstructured":"Xu L, Mei M, Haskins ME, Nichols TC, O'Donnell P, Cullen K, Dillow A, Bellinger D, Ponder KP: Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice. Thromb Res. 2007, 120: 269-280.","journal-title":"Thromb Res"}],"container-title":["Genetic Vaccines and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-0556-9-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-0556-9-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-0556-9-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:21:34Z","timestamp":1630502494000},"score":1,"resource":{"primary":{"URL":"https:\/\/gvt-journal.biomedcentral.com\/articles\/10.1186\/1479-0556-9-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1186\/1479-0556-9-8","relation":{},"ISSN":["1479-0556"],"issn-type":[{"value":"1479-0556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,8]]},"assertion":[{"value":"1 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}